Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Structural insights into activation of antiviral NK cell responses.

Finton KA, Strong RK.

Immunol Rev. 2012 Nov;250(1):239-57. doi: 10.1111/j.1600-065X.2012.01168.x. Review.

2.

Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience.

Vidal SM, Khakoo SI, Biron CA.

Curr Opin Virol. 2011 Dec;1(6):497-512. doi: 10.1016/j.coviro.2011.10.017. Review.

3.

Viral evasion of natural killer cells.

Orange JS, Fassett MS, Koopman LA, Boyson JE, Strominger JL.

Nat Immunol. 2002 Nov;3(11):1006-12. Review.

PMID:
12407408
4.

Regulatory NK cells in autoimmune disease.

Tian Z, Gershwin ME, Zhang C.

J Autoimmun. 2012 Sep;39(3):206-15. doi: 10.1016/j.jaut.2012.05.006. Epub 2012 Jun 15. Review.

PMID:
22704425
5.

Immune evasion of natural killer cells by viruses.

Jonjić S, Babić M, Polić B, Krmpotić A.

Curr Opin Immunol. 2008 Feb;20(1):30-8. doi: 10.1016/j.coi.2007.11.002. Review.

6.

Natural killer cell immune responses.

Yokoyama WM.

Immunol Res. 2005;32(1-3):317-25. Review.

PMID:
16106081
7.
8.

The evolutionary arms race between NK cells and viruses: who gets the short end of the stick?

Miletić A, Krmpotić A, Jonjić S.

Eur J Immunol. 2013 Apr;43(4):867-77. doi: 10.1002/eji.201243101. Epub 2013 Mar 18. Review.

9.

A bird's eye view of NK cell receptor interactions with their MHC class I ligands.

Saunders PM, Vivian JP, O'Connor GM, Sullivan LC, Pymm P, Rossjohn J, Brooks AG.

Immunol Rev. 2015 Sep;267(1):148-66. doi: 10.1111/imr.12319. Review.

PMID:
26284476
10.

Natural killer cell licensing during viral infection.

Orr MT, Lanier LL.

Adv Exp Med Biol. 2011;780:37-44. doi: 10.1007/978-1-4419-5632-3_4. Review.

PMID:
21842363
11.

Modulation of natural killer cell activity by viruses.

Lisnić VJ, Krmpotić A, Jonjić S.

Curr Opin Microbiol. 2010 Aug;13(4):530-9. doi: 10.1016/j.mib.2010.05.011. Epub 2010 Jun 16. Review.

12.

NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome.

Pyzik M, Kielczewska A, Vidal SM.

Semin Immunol. 2008 Dec;20(6):331-42. doi: 10.1016/j.smim.2008.09.003. Epub 2008 Oct 22. Review.

PMID:
18948016
13.

The innate immune response to tumors and its role in the induction of T-cell immunity.

Diefenbach A, Raulet DH.

Immunol Rev. 2002 Oct;188:9-21. Review.

PMID:
12445277
14.

Natural killer cells: fighting viruses and much more.

Colonna M, Jonjic S, Watzl C.

Nat Immunol. 2011 Feb;12(2):107-10. doi: 10.1038/ni0211-107.

PMID:
21245897
15.

Here today--not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections.

Lee SH, Biron CA.

Eur J Immunol. 2010 Apr;40(4):923-32. doi: 10.1002/eji.201040304. Review.

16.

Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?

Zhang C, Zhang J, Wei H, Tian Z.

Int Immunopharmacol. 2005 Jul;5(7-8):1099-111. Epub 2005 Apr 1. Review.

PMID:
15914316
17.

[Recognition of virus infected cells by NK cells].

Arase H, Shiratori I.

Uirusu. 2004 Dec;54(2):153-60. Review. Japanese.

18.

NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer.

Cerwenka A, Lanier LL.

Tissue Antigens. 2003 May;61(5):335-43. Review.

PMID:
12753652
19.

Natural killer cells and cancer.

Wu J, Lanier LL.

Adv Cancer Res. 2003;90:127-56. Review.

PMID:
14710949
20.

Successful control of viruses by NK cells--a balance of opposing forces?

Scalzo AA.

Trends Microbiol. 2002 Oct;10(10):470-4. Review.

PMID:
12377557
Items per page

Supplemental Content

Write to the Help Desk